← Back to BIIB

BIOGEN INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 29/04/2026Sep 2025Filed 30/10/2025Jun 2025Filed 31/07/2025Mar 2025Filed 29/04/2026Sep 2024Filed 30/10/2025Jun 2024Filed 31/07/2025Mar 2024Filed 01/05/2025Sep 2023Filed 30/10/2024
$2,478$2,535$2,646$2,431$2,466$2,465$2,291$2,530
$320$467$635$241$389$584$393−$68
$2.15$3.17$4.33$1.64$2.66$4.00$2.70−$0.47
148147147147146146146145

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.